La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

R. Raisman-Vozari And NotPhysiopathologie

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000C33 C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio ; Fabrizio StocchiLevodopa in the treatment of Parkinson's disease: Current controversies
000E94 T. Debeir [France] ; M. Marien [France] ; P. Chopin [France] ; J.-C. Martel [France] ; F. Colpaert [France] ; R. Raisman-Vozari [France]Protective effects of the α2-adrenoceptor antagonist, dexefaroxan, against degeneration of the basalocortical cholinergic system induced by cortical devascularization in the adult rat
001177 M. G. Murer [France, Argentine] ; G. Dziewczapolski [Argentine] ; P. Salin [France] ; M. Vila [France] ; K. Y. Tseng [Argentine] ; M. Ruberg [France] ; M. Rubinstein [Argentine] ; M. A. Kelly [États-Unis] ; D. K. Grandy [États-Unis] ; M. J. Low [États-Unis] ; E. Hirsch [France] ; R. Raisman-Vozari [France] ; O. Gershanik [Argentine]The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice
001235 W.-J. Gu [France] ; N. Abbas [France] ; M. Z. Lagunes [France] ; A. Parent [France] ; L. Pradier [France] ; G. A. Bohme [France] ; Yves Agid [France] ; E. C. Hirsch [France] ; R. Raisman-Vozari [France] ; A. Brice [France]Cloning of rat parkin cDNA and distribution of parkin in rat brain
001302 M. Vila [France] ; C. Marin [Espagne] ; M. Ruberg [France] ; A. Jimenez [Espagne] ; R. Raisman-Vozari [France] ; Yves Agid [France] ; E. Tolosa [Espagne] ; E. C. Hirsch [France]Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia
001307 K. Parain [France] ; M. G. Murer [France] ; QIAO YAN [États-Unis] ; B. Faucheux [France] ; Yves Agid [France] ; E. Hirsch [France] ; R. Raisman-Vozari [France]Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra
001326 M. G. Murer [Argentine] ; R. Raisman-Vozari [France] ; O. Gershanik [Argentine]Levodopa in Parkinson's disease : Neurotoxicity issue laid to rest?
001463 M. G. Murer [France] ; G. Dziewczapolski [Argentine] ; L. B. Menalled [Argentine] ; M. C. Garcia [Argentine] ; Yves Agid [France] ; O. Gershanik [Argentine] ; R. Raisman-Vozari [France]Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions
001595 C. Adelbrecht [France] ; M. G. Murer [France] ; I. Lauritzen [France] ; F. Lesage [France] ; M. Ladzunski [France] ; Yves Agid [France] ; R. Raisman-Vozari [France]An immunocytochemical study of a G-protein-gated inward rectifier K+ channel (GIRK2) in the weaver mouse mesencephalon
001599 G. Dziewczapolski [Argentine] ; G. Murer [France] ; Yves Agid [France] ; O. S. Gershanik [Argentine] ; R. Raisman-Vozari [France]Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned rats
001655 C. Adelbrecht [France] ; Yves Agid [France] ; R. Raisman-Vozari [France]Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area
001657 V. Blanchard [France] ; P. Anglade [France] ; G. Dziewczapolski ; M. Savasta [France] ; Yves Agid [France] ; R. Raisman-Vozari [France]Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra
001722 V. Blanchard [France] ; M. Chritin ; SHEELA VYAS [France] ; M. Savasta ; C. Feuerstein ; Yves Agid [France] ; F. Javoy-Agid [France] ; R. Raisman-Vozari [France]Long-term induction of tyrosine hydroxylase expression : compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain
001896 Yves Agid [France] ; M. Ruberg ; F. Javoy-Agid ; E. Hirsch ; R. Raisman-Vozari ; S. Vyas ; B. Faucheux ; P. Michel ; A. Kastner ; V. Blanchard ; P. Damier ; J. Villares ; PING ZHANGAre dopaminergic neurons selectively vulnerable to Parkinson's disease ?
001A54 R. Raisman-Vozari ; J.-A. Girault ; S. Moussaoui ; C. Feuerstein ; P. Jenner ; C. D. Marsden ; Yves Agid [France]Lack of change in triatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024